Translational neuroscience for Alzheimer's Disease
We are interested in disorders that impact human cognition. In particular, this includes Alzheimer's, Fronto-temporal dementia and Traumatic Injury. We seek to define the molecular, cellular and circuit basis for impaired cognition in each of these conditions. Furthermore, we seek to develop therapeutics to reverse or overcome the dysfunction and apply this knowledge to develop therapeutics. Our work includes mouse models of disease and human translation in clinical trials.
Stephen Strittmatter, MD, PhD, earned his undergraduate degree from Harvard, and completed doctoral training at Johns Hopkins. His medical internship and neurology residency were at Massachusetts General Hospital. He joined the Yale faculty in 1993, and is now Chair and Professor of Neuroscience and Vincent Coates Professor of Neurology.